Last updated on November 2017

Pfizer A4091059


Brief description of study

Pfizer A4091059

Detailed Study Description

The purpose of this research study is to compare the effects of the investigational study drug, tanezumab, with another drug called tramadol (also called Tradorec XL®, prolonged release tablets) and a placebo to find out which is better for treating chronic low back pain. Tramadol is a drug that is approved by the United States Food and Drug Administration (FDA) to treat moderate to severe pain in adults and children over 12 years. Tanezumab is an investigational drug.

Clinical Study Identifier: TX5342

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ryan Griffin

OtriMed Clinical Research
Edgewood, KY USA
  Connect »

Holly Dickens

OtriMed Clinical Research
Edgewood, KY USA
  Connect »